S
AQST icon

SignatureFD’s Aquestive Therapeutics AQST Stock Holding History

SignatureFD’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32K Hold
2,000
– – ﹤0.01% 2705
2026
Q1 		$8.3K Sell
2,000
-93
-4% -$377 ﹤0.01% 2584
2025
Q4 		$13.5K Buy
+2,093
New +$13K ﹤0.01% 2297

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
ACA
Adirondack Capital Advisors Syracuse, New York $186M AUM
CCM
Cox Capital Management Andover, Massachusetts $180M AUM 40.44% 1-Year Est. Return
LWA
Lineweaver Wealth Advisors Valley View, Ohio $845M AUM 20.71% 1-Year Est. Return

SignatureFD's AQST Position: Q2 2026 in Review

SignatureFD held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 2,000 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #2705.

SignatureFD first reported a position in AQST in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.5K in Q4 2025. 22 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • SignatureFD held 2,000 shares of Aquestive Therapeutics worth $8.32K as of Q2 2026.
  • SignatureFD left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2705 holding.
  • SignatureFD first reported a position in Aquestive Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • SignatureFD's Aquestive Therapeutics position peaked at $13.5K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.